171 articles for regulatory affairs professionals in pharma, biotech and medical devices: career guidance, role profiles, hiring trends and policy explainers. Updated Oct 10, 2026.
5,000+ job seekers
joined our newsletter
Showing 1–12 of 25 articles
How the growing pipeline of psychedelic-assisted therapies, including psilocybin and MDMA-based treatments, is creating distinct regulatory hiring demand.
Continuous manufacturing is reshaping CMC regulatory work, from control strategy to real-time release testing. Here's what the hiring niche actually looks like.
Live biotherapeutic products don't fit neatly into existing regulatory pathways. Here's what that means for regulatory affairs hiring and careers.
Decentralized clinical trials add regulatory touchpoints around consent, delegation, and data chain of custody. What that means for regulatory affairs careers.
Investment and product activity in women's health and femtech are creating new regulatory affairs demand across contraceptives, fertility tech, and diagnostics. Here's what the work involves.
Antimicrobial resistance programs are creating steady regulatory affairs demand around QIDP, LPAD, and antibiotic development pathways. Here's what the work involves.
Expanded access and compassionate use programs are creating specialized regulatory affairs work. Here's what the role involves and why demand is growing.
Why mRNA and RNA-based therapeutics are creating distinct regulatory affairs hiring demand, what the work involves, and how to position yourself for it.
Rx-to-OTC switch programs need regulatory pros fluent in both prescription and nonprescription rules. Why this hiring niche exists and how to break into it.
ADCs combine biologic and small-molecule review questions in one submission. Here's why that is creating a specialized regulatory affairs hiring niche.
How ongoing nitrosamine impurity risk assessment and remediation work is creating steady, specialized CMC regulatory affairs hiring demand across pharma.
Why contract manufacturers need a different flavor of regulatory affairs talent than sponsors do, and what that means for job seekers weighing a move.
